Related Experiment Videos

ABCB1 genotype is associated with fentanyl requirements in critically ill children

Christopher M Horvat1, Alicia K Au1, Yvette P Conley2

  • 1Department of Critical Care Medicine, Safar Center for Resuscitation Research and the Brain Care Institute at the Children's Hospital of Pittsburgh of UPMC, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.

Pediatric Research
|April 8, 2017
PubMed

Insights

The ABCB1 genotype rs1045642 AA variant is linked to reduced fentanyl requirements in critically ill children. This finding suggests genetic variations in ABCB1 influence opioid dosing in pediatric intensive care units.

Area of Science:

  • Pharmacogenetics
  • Critical Care Medicine
  • Pediatric Anesthesiology

Background:

  • The ABCB1 gene encodes p-glycoprotein, an efflux pump affecting opioid transport.
  • ABCB1 genotype may influence fentanyl dosing in critically ill children.

Purpose of the Study:

  • To investigate the association between ABCB1 genotype and fentanyl requirements in pediatric intensive care unit (PICU) patients.
  • To examine the relationship between fentanyl dosing, pain/sedation scores, serum fentanyl levels, and ABCB1 genotype.

Main Methods:

  • Studied a cohort of 61 children receiving fentanyl infusions in the PICU.
  • Analyzed associations between fentanyl requirements, pain/sedation scores, serum fentanyl levels, and ABCB1 genotype (rs1045642).

Main Results:

  • Patients with the ABCB1 rs1045642 AA allele required significantly less fentanyl (18.6 mcg/kg/day less) compared to AG or GG alleles.
  • The AA allele was associated with lower fentanyl administration, potentially due to reduced p-glycoprotein activity.

Conclusions:

  • ABCB1 genotype rs1045642 AA is associated with altered fentanyl administration in critically ill children.
  • Further prospective studies are warranted to evaluate ABCB1's role in sedative-analgesia for critically ill pediatric patients.

Related Concept Videos